BioSpace News Archive

Biotech Beach

Endonovo Therapeutics Releases A Comparative Analysis Addressing Limitations Of Non-Opioid Pharmaceutical Interventions on the Reduction of Opioid/Narcotic Use For Post-Surgical Pain Management

Endonovo Therapeutics Inc. (OTCQB:ENDV) today released a comparative analysis detailing how its SofPulse® medical device out-performed all pharmaceutical competitors non-opioid alternatives for surgical pain management.

July 21, 2022
·
8 min read
Drug Development

Neuraptive Therapeutics Announces First Patient Enrolled in a Phase 2 Trial of NTX-001 for the Prevention of Facial Paralysis and Provides Update on the Phase 2 Study of NTX-001 in Peripheral Nerve Injuries due to Trauma

Neuraptive Therapeutics, Inc. (Neuraptive), today announced the enrollment of the first patient in its Phase 2a clinical trial evaluating the safety and efficacy of NTX-001 compared to the standard of care in the treatment and prevention of facial paralysis.

July 21, 2022
·
2 min read
BioCircuit Technologies Announces FDA 510(k) Clearance of Nerve Tape® Device

BioCircuit Technologies®, a National Institutes of Health (NIH)-funded medical device company focused on tissue repair and neuromodulation, announced today it has received FDA 510(k) clearance for its nerve repair device, Nerve Tape®.

July 21, 2022
·
2 min read
Biotech Bay

Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth Conference

Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the upcoming 42 nd Annual Canaccord Genuity Global Growth Conference in Boston, MA.

July 21, 2022
·
2 min read
Business

Insmed to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022

Insmed Incorporated today announced that it will release its second quarter 2022 financial results on Thursday, August 4, 2022.

July 21, 2022
·
1 min read
Business

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2022 Financial Results

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its second quarter 2022 financial results and provide an update on the company’s business and outlook on Thursday, Aug. 4 , at 4:30 p.m. ET .

July 21, 2022
·
1 min read
Business

Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022

Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2022 financial results will be released on Thursday, August 4, 2022, after the close of the stock market.

July 21, 2022
·
1 min read
Business

Apollo Endosurgery to Report Second Quarter Results on August 2, 2022

Apollo Endosurgery, Inc. today announced that the Company is scheduled to release financial results for the second quarter ended June 30, 2022 on Tuesday, August 2, 2022, after market close.

July 21, 2022
·
2 min read
Business

Kallyope and Brightseed Enter Collaboration to Identify and Validate Novel Plant-Based Bioactives

Kallyope and Brightseed have entered a strategic research collaboration to screen plant compounds to identify and validate active agents.

July 21, 2022
·
5 min read
Business

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2022 Financial Results

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2022 financial results will be released on Thursday, August 4, 2022 after the market closes.

July 21, 2022
·
1 min read